As a result of the merger of Al Mokhtabar and Al Borg Laboratories in 2012, Integrated Diagnostics Holdings (IDH) was created with a vision of becoming one of the largest pure emerging market diagnostic groups. IDH provides more than 1,000 diagnostic services, including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories operating through 6 different brands, over 290 branches and 4 central labs across the Middle East.
In May 2015
The initial public offering (IPO) of Egypt’s largest medical diagnostics company on the London Stock Exchange was 11.2 times oversubscribed suggesting heavy foreign appetite for an Egyptian firm operating across the Middle East.
EFG Hermes was the joint global coordinator and joint book-runner on the IPO which offered 43.5% of IDH shares in the first ever IPO for a medical firm operating in Egypt in London Stock Exchange since 2008.
Commenting on the listing Dr. Hend El Sherbini, Chief Executive Officer at IDH, said:
“Today represents a key milestone in the IDH growth story. Our initial public offering will allow us to further accelerate our market penetration. Increase our profile and brand recognition, expand our service offerings in our target markets. We warmly welcome our new investors to share in the next, exciting stage of our growth and development.”
We commit to provide healthcare excellence....
To be the leader in health care service & the “Provider of Choice” in the Middle East & Africa.
Our professional & innovative team will deliver “best in class” quality and cost effective services....
Care In all its accomplishments, IDH is guided by the needs of its patients.
IDH actively supports outstanding programs of education and training designed to enhance the knowledge and skills that are of value to their staff....